university curriculum vitae format€¦ · web viewcurriculum vitae date: april 30, 2018 name:...

CURRICULUM VITAE

DATE: April 30, 2018

NAME: Seena C. Aisner, M.D.

PRESENT TITLE: Professor and Vice-Chair of Pathology and Laboratory Medicine

OFFICE ADDRESS: 185 South Orange Avenue, MSB C 579, Newark, NJ 07103

EDUCATION:A. Undergraduate and Professional

Queens College of the City of New York 1966 – 1967Queens, New York

Wayne State UniversityDetroit, MichiganB.S. (Dean's Honor List) 1969

B. Graduate

Wayne State University College of Medicine 1969 - 1971Detroit, Michigan

George Washington University School of Medicine 1973 Washington, D.C. M.D.

POSTGRADUATE TRAINING:A. Internship and Residencies

The Johns Hopkins Hospital, Baltimore, Maryland1st and 2nd year Anatomical Pathology Residence1973-1975

The Johns Hopkins Hospital, Baltimore, Maryland 1st and 2nd year Clinical Pathology Residency1975-1977

B. Research Fellowships: NA

C. Postdoctoral Appointments: NA

MILITARY: NA

ACADEMIC APPOINTMENTS:

of 30

Department of Pathology and Laboratory MedicineRutgers New Jersey Medical SchoolProfessor and Vice ChairDirector, Residency Training ProgramDecember 2015-present

Department of Pathology and Laboratory MedicineRutgers (formerly UMDNJ) – New Jersey Medical SchoolProfessor and Chair (interim)January 2012-November 2015

Cancer Institute of New Jersey, New Brunswick, New JerseyAssociate MemberJanuary 1997 - present

International Association for the Study of Lung Cancer, Pathology PanelMember1982-1998

International Association for the Study of Lung Cancer, Pathology PanelMember and member, Pathology Panel, World Health Organization (WHO)2010-2015

Department of Pathology Residency Training ProgramUMDNJ – New Jersey Medical SchoolDirectorSeptember 2006 - present

Chair, Lung PathologyEastern Cooperative Oncology Group1987- present

Pathology CommitteeEastern Cooperative Oncology GroupMember1982 – present

Department of PathologyUMDNJ – New Jersey Medical SchoolProfessor and Vice ChairMay 1995 -2012

Department of PathologyUniversity of Maryland Graduate SchoolProfessorJuly 1993 – May 1995

University of Maryland Graduate SchoolAssociate Member – Graduate Faculty

of 30

July 1989 – May 1995

Residency Advisory CommitteeUniversity of Maryland Medical CenterMember1988-1995

Department of PathologyUniversity of Maryland School of MedicineAssistant Professor of OncologyFebruary 1987 – May 1995

Pathology DepartmentDruid Hill Disease Laboratory, City of BaltimoreDirectorMay 1987 – May 1995

University of Maryland Cancer CenterUniversity of Maryland School of MedicineAssociate Professor of OncologyJuly 1990 – June 1993

Department of PathologyUniversity of Maryland School of MedicineAssociate Professor of PathologyJuly 1990 – June 1993

Department of SurgeryUniversity of Maryland School of MedicineMedical School Associate Professor (secondary)July 1988 – June 1993

Department of PathologyUniversity of Maryland School of MedicineAssistant Professor of PathologyFebruary 1987 – June 1990

Eastern Cooperative Oncology GroupScientific Advisory CommitteeJanuary 1992-present

Eastern Cooperative Oncology GroupScientific Advisory Committee Site VisitSeptember 1991?

Lung Pathology Review PanelEastern Cooperative Oncology GroupCo-Chair1982-1987

of 30

HOSPITAL APPOINTMENTS:

Department of Pathology and Laboratory MedicineUniversity Hospital, Newark, NJChief of ServiceNovember 2009 to Present

Anatomic Laboratories, Department of Pathology and Laboratory MedicineUniversity Hospital, Newark, NJDirectorMay 1995 - present

Director, Pathology Residency Training Program, Department of Pathology and Laboratory MedicineUniversity Hospital, Newark, NJSeptember 2006 - present

Director, Autopsy Services, Department of Pathology and Laboratory MedicineUniversity Hospital, Newark, NJDirectorFebruary 1998 -2006

Cytology, Department of Pathology and Laboratory MedicineUniversity Hospital, Newark, NJDirectorNovember 1997 – April 2001

Department of PathologyUniversity of Maryland School of Medicine ProfessorJuly 1993 – May 1995

Division of Cytology, Department of PathologyUniversity of Maryland School of MedicineDirectorApril 1988 – May 1995

Cytopathology Fellowship ProgramUniversity of Maryland School of MedicineDirectorJuly 1993 – June 1994

Surgical PathologyUniversity of Maryland School of MedicineAssociate DirectorFebruary 1987 – June 1991

Department of Pathology-Hematology Lab Franklin Square Hospital, Baltimore, MDDirector June 1977 – June 1986

Department of Pathology-Blood Bank

of 30

Franklin Square Hospital, Baltimore, MDDirector June 1977 – June 1986

Associate PathologistFranklin Square Hospital, Baltimore, MDDirector, Blood BankJune 1979 – June 1986

OTHER EMPLOYMENT OR MAJOR VISITNG APPOINTMENTS: NA

PRIVATE PRACTICE: NA

LICENSURE: Maryland D 18568 (inactive) New Jersey 62571 (expires 6/30/19) New Jersey Bioanalytical Laboratory Director 71300 (expires 6/30/19)

DRUG LICENSURE:CDS: D06800300/expiration 10/31/19DEA: AA9074977/expiration 6/30/19

CERTIFICATION: National Board of Medical Examiners, 1974 American Board of Anatomic Pathology, 1977

American Board of Clinical Pathology, 1977American Board of PathologyQualification in Cytopathology, 1989

MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES: NA

HONORS AND AWARDS:Junior Arista 1965Senior Arista 1966Dean's List of Honor Students - Biology 1969Sophomore Pathology Preceptorship 1970Anesthesiology Preceptorship 1971Alpha Omega Alpha - Honor Medical Society 1973New Jersey Top Docs, New Jersey Monthly, Vol 23, No.11

November, 1998Public Medical Education Award for Service to the Community May 2006.American Society Anesthesiology, 2nd place (abstract # 61)

of 30

BOARDS OF DIRECTORS/TRUSTEES POSITIONS: NA

SERVICE ON NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES: NA

SERVICE ON MAJOR COMMITTEES:

A. International: NAB. National: NAC. Medical School/University: D. Hospital:E. Department:F. Editorial BoardsG. AdHoc Reviewer

Chairman, Transfusion Practices Committee, Franklin Square Hospital, Baltimore, Maryland, 1979-1986

Chairman, Research and Human Volunteers Committee, Franklin Square Hospital, Baltimore, Maryland, 1979-1981

Member, Quality Assurance Committee, Franklin Square Hospital, Baltimore, Maryland, 1979-1985

Inspector, College of American Pathologists, 1980-present

Member Lung Pathology Review Panel, Eastern Cooperative Oncology Group, 1981-1986

Co-chairman, Lung Pathology Review Panel, Eastern Cooperative Oncology Group, 1982-1987

Member, Pathology Panel, International Association for the Study of Lung Cancer, 1982-1998

Member, Pathology Committee, Eastern Cooperative Oncology Group, 1982-present

Chairman, Lung Pathology, Eastern Cooperative Oncology Group, 1987-present

Director, Department of Pathology Residency Training Program Committee, University of Maryland, 1988-1995

Member, University of Maryland Medical Center Residency Advisory Committee, 1988-1995

Scientific Advisory Committee Site Visit, Eastern Cooperative Oncology Group, Madison, Wisconsin, Sept 1991

Scientific Advisory Committee, Eastern Cooperative Oncology Group, Madison, Wisconsin January 1992n,

Member, Cancer Clinical Investigation Review Committee (CCIRC), National Cancer Institute, 7/95-6/99

Site Visit: North Central Cancer Treatment Group NCCTG), Rochester, Minnesota, October 29-31, 1995.

Site Visit: NSABP, Pittsburgh, Pennsylvania, February 6-8, 1996.

Site Visit: Radiation Therapy Oncology Group (RTOG), Philadelphia, Pennsylvania, May 1-3, 1996.

Site Visit: IRS (Rhabdomyosarcoma Study Group), Monrovia, California, June 24-26, 1996.

of 30

Site Visit: IBCSG (International Breast Cancer Study Group, formerly Ludwig Breast Cancer Study Group), Amherst, New York, April 7-9, 1997

Site Visit: European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium, June 24, 26, 1997.

Site Visit: Cancer and Acute Leukemia Group B (CALGB), Durham, North Carolina, October 7-10, 1997

Site Visit: Children's Cancer Group (CCG) Monrovia, California, June 2-5, 1998

Site Visit: NCI-NIH RFA ZCA1 GRB-V (J1) SPORE Specialized Programs of Research Excellence in Lung Cancer and Prostate Cancer Washington, D.C. October, 2000.

Site Visit: NCI Gynecology Oncology Group (GOG) Bethesda, Maryland, November 14-15, 2001

Site Visit: NCI SPORE Specialized Programs of Research Excellence in Lung Cancer and Gastrointestinal Cancer, Washington, D.C. October, 2002

Site Visit: NCI- Molecular Based Therapy for Oral Cancer Prevention, Houston, Texas October, 2003

Reviewer, NCI-NIH RFA CA 104201-01 Special Programs of Research Excellence in Ovarian Cancer (SPORE) May, 2004

Member, Peer Review Committee, Ambulatory and Preventative Medicine for Year 4 students, University of Maryland School of Medicine, February 1994

Reviewer, NCI-NIH RFA CA91-34 Specialized Programs of Research Excellence in Lung Cancer (SPORE), May 1992

Member, Basic Science Subcommittee for Curriculum reform, University of Maryland School of Medicine. Oct.1992-Jan. 1994

Board Member, University Physician Associates , New Jersey Medical School, Oct. 1995-present

Member, Pathology Panels of the World Health Organization and the International Association for the Study of Lung Cancer (IASLC) Pathology Panel. 3/95-2005

Member, Editorial Board, Lung Cancer, 8/96-8/98

Co-Director, Residency Training Program, UMDNJ-New Jersey Medical School, 1996-2006

Member, Practice Committee, American Society of Cytopathology, 5/97-5/99

Director, Residency Training Program, Department of Pathology New Jersey Medical School., 9/06-present

Breast Cancer Eligibility Study, NCI, Bethesda, Maryland 5/4/98-5/6/98

Member, Review Committee, University Physician Associates, Newark, New Jersey, 7/97-present

Member, Standards Committee, American Society of Cytology, 6/96-2000

Member, Office and Space Committee, UMDNJ, New Jersey Medical School 5/97-present

of 30

Member, Faculty Committee on Appointments and Promotions, UMDNJ, New Jersey Medical School9/97-2000

Member, Lung Cancer Reporting Standards Committee, NCI, Chicago, Illinois. 6/1/2001

Member New Jersey Med, PC, Reimbursement Committee, 9/2001-present

Site Visit, Gynecology Oncology Group (GOG), Bethesda, Maryland11/14/2001

Member, Editorial Board, Human Pathology, 7/2002-present

Member, Cytology Panel, Early Lung Cancer Action Program, (ELCAP), Cornell-Weill Medical College, New York City, New York. 7/2002-2005

Site Visit, International Breast Cancer Study Group (IBCSG) Site Visit, Cancer and Acute Leukemia, Group B11, Rockville, Maryland. /6-11/8-2005 Consultant, Rutgers Law School, Newark, New Jersey, 11/2005

Member, Faculty Counsel on Appointments and Promotions UMDNJ/New Jersey Medical School, Newark, New Jersey 9/07-2009

Reviewer, Department of Defense Grant, Peer-Reviewed Medical Research Program on Malignant Mesothelioma Rockville, Maryland 9/2008

Member, Pathology Panel, International Association for the Study of Lung Cancer. 2/2010

Member Search Committee, Department of Dental Medicine NJMS. 2/2011-6/2011

Site Visit, NCTN Bio-specimen Banks U24 Review (CA14-501) National Institutes of Health, National Cancer Center, Bethesda, Maryland 11/2014

Member, Search Committee, Director, Molecular Pathology, Rutgers NJMS 3/17-present

Director, Search Committee, Surgical Pathology, Rutgers NJMS 3/17-present

SERVICE ON GRADUATE SCHOOL COMMITTEES:

Member, Graduate Medical Education Committee, April 1995-present

SERVICE ON HOSPITAL COMMITTEES: Member, Chief of Service Committee, Nov 2009- present.

SERVICE TO THE COMMUNITY:

SPONSORSHIP (Primary Mentorship) OF CANDIDATES FOR POSTGRADUATE DEGREE: NA

SPONSORSHIP (Primary Mentorship) OF POSTDOCTORAL FELLOWS: NA

of 30

TEACHING RESPONSIBILITIES: A. Lectures or Course DirectorshipsUMDNJ/NJMS Sophomore Integrated Pathology, Pulmonary Pathology, 1995-PresentResearch Training (other than Primary Mentorship)

Post Doctoral Fellows: NA

Pre Doctoral Students: NA

CLINICAL RESPONSIBILITIES:

Director, Anatomic Pathology, University Hospital, Newark, NJ. 1995-2012Chief of Service, University Hospital, Newark, NJ November 2009-presentHolder, Clinical Lab Improvement Act (CLIA), University Hospital

GRANT SUPPORT: A. Principal Investigator

1. Cancer Institute of New Jersey, CCSG, Tissue Acquisition Services, 2009-20132. American Cancer Society Fellowship Grant Award, 1988-1993, $40,0003. Angelini Pharmaceuticals (Pathology Reviewer), Lonidamine as a Radiosensitizer in

advanced non-small Cell Lung Cancer, 1990-1991,$20,000

B. Co-Investigator1. UMDNJ-NJMS, Prostaglandin Receptors as Therapeutic Targets for Prostate Cancer, 2008-

20122. Eastern Cooperative Oncology Group, Pathology Correlative Studies for E5597 Lung Cancer

Clinical Trial, 2003 – present, $348,7093. National Institutes of Health RO1-CA 41566, Growth Control of Normal and Malignant

Keratinocytes Co-Investigator, 2003-present ,$ 250,0004. NHLBI 1R2 HL077462-01, Pathogen Specificity Immunity in Sarcoidosis 2004-2008,

$275,0005. National Institutes of Health, NCI; CA21115, Eastern Cooperative Oncology Group (ECOG),

1982-2003 6. National Institutes of Health, NCI;N01-C-95624, Resource for Collection of Tissues from

Patients with an Epidemiologic Profile, 1989-19957. National Institutes of Health, NCI;N01-CP-51000, Resource for Collection of Tissues from

Patients with an Epidemiologic Profile, 1987-1989

C. Pending

PUBLICATIONS:

A. Refereed Original Article in Journal

1. Merimee TJ., Ostrow P., Aisner S.C.: Clinical pathological studies in a growth hormone deficient dwarf. The Johns Hopkins Medical Journal. 1975 Mar; 136 (3): 150-54. PMID: 1117599

of 30

2. Aisner, S.C., Gupta, P.K., Frost, J.K.: Sputum cytology in pulmonary sarcoidosis. ACTA Cytologica 1977 May-Jun;21(3): 394-398. PMID: 2681118.

3. Aisner J., Satterfield JR., Aisner SC., Pyeatte J., Wiernik PH.: Inflammatory changes related to active tuberculosis. Chest. 1978 May; 73 (5): 670-672. PMID: 206415

4. Aisner, J., Aisner, S.C., Ostrow, S., Govindan, S., Mummert, K., Wiernik, P.H.: Meningeal carcinomatosis from small cell carcinoma of lung, consequence of improved survival. ACTA Cytologica 1979 Jul-Aug;23 (4): 292-9. PMID: 231364.

5. Ayulo M., Aisner SC., Margolis K, Moravec C.: Cytomegalovirus-associated gastritis in a compromised host. JAMA 1980 Apr4; 243 (13): 1364. PMID: 6244422.

6. Arnett EN., Aisner SC., Lewis KB., Tecklenberg P., Brawley RK., Roberts WC.: Pulmonic valve stenosis, atrial septal defect and left to right interatrial shunting with intact ventricular septum. A Distinct hemodynamic-moprhologic syndrome. Chest 1980 Nov;78 (5): 759-62. PMID: 6448732.

7. Berger C., Goodwin G., Mendelsohn G., Eggleston J., Abeloff M., Aisner SC., Baylin S.: Endocrine biochemistry in the spectrum of human lung carcinoma. J Clinical Endocrinol Metab 1981 Aug;53(2): 422-9. PMID: 6114110.

8. Ayulo MA., Dibos PE., Aisner SC., Moravec CL.: Gallium 67 Citrate scanning in primary mediastinal seminoma. J Nucl Med 1981 Sept; 22(9): 796-7. PMID: 6944442.

9. Aisner SC., Khaneja S., Ramierez O.: Multiple granular cell tumors of the gallbladder and biliary tree: a case report. Arch Path Lab Med 1982 Sep; 106(9): 470-1. PMID: 6287960.

10. Roberts WC., Arnett EA., Cabin HS., McIntoch CL., Aisner SC., Kent KM., Lewis KB.: Documentation of development of severe stenosis of previously normally functioning aortic valves. American Heart Journal 1982 Aug; 104(2) Pt 1): 306-8. PMID: 7102515.

11. Aisner SC., Aisner J., Moravec C., Arnett, EN.: Acquired Toxoplasmic lymphadenitis with demonstration of the cyst form. American Journal of Clinical Pathology 1983 Jan;79(1): 125-7 PMID: 6849288.

12. Roberts WC., Arnett EA., Aisner SC., Tecklenberg P.: Aortic valve stenosis and left ventricular aneurysm and/or rupture: Real or potential complications of persistent left ventricular systolic hypertension after acute myocardial infarction. Am Heart J. 1983 Mar; 105(3): 513-4. PMID: 6829412.

13. Yesner R., Aisner SC., Campobosso O., Elema JD., Gazdar AF., Hirsch FR., Matthews, M., MacKay B.: Classification of lung cancer histology. New England J Med. 1985 312 (10): 652-653.

14. Aisner SC., Albin RJ.: Diffuse interstitial pneumonitis and fibrosis in sarcoidosis. Chest..1988 Jul; 94 (1): 193-5. PMID: 3383632.

15. Hirsch, F.R., Matthews, M.J., Aisner, S.C., Campobasso, P., Elema, J.D., Gazdar, A.F., MacKay, B., Nasiell, M., Shimosato, Y., Steele, R.H., Yesner, R., and Zettergren, L.: Histopathologic

of 30

classification of small cell lung cancer. Changing concepts and terminology. Cancer. 1988 Sep 1; 62(5):973-7.PMID: 2842029.

16. Young JWR., Aisner SC., Levine AM., Resnik CS Dorfman HD.: Computed tomography of desmoplastic fibroma. Skeletal Radiol. 1988; 17 (5): 333-7. PMID: 3175691.

17. Aisner SC., Chakravarthy A., Joslyn JN., Coghlin T.: Bilateral granular cell tumors of the posterior mediastinum. Ann Thorac Surg. 1988 Dec; 46(6): 688-9. PMID: 2848464.

18. Resnik CS., Levine AM., Aisner SC., Young JWR., Dorfman HD.: Concurrent adjacent osteochondroma and enchondroma. Skeletal Radiol. 1989;18(1): 66-9. PMID: 2711213.

19. Resnik CS., Young JWR, Levine AM., Aisner SC.: Metastatic chordoma to humeri (originating in sacrum). Skeletal Radiol. 1989; 18 (1): 66-9. PMID: 2781329.

20. Resnik CS., Young JWR., Aisner SC., Levine A.: Osseous sarcoidosis (osteolytic) of lumbar spine and pelvis. A case report. Skeletal Radiol. 1990; 19(3): 217-9. PMID: 2326664.

21. Aisner SC., Finkelstein DM, Ettinger DS., Abeloff MD., Ruckdeschel JC., Eggleston, JC.: The clinical significance of variant morphology (small cell/large cell) small cell carcinoma of the lung (SCCL). J Clin Oncol. 1990 Mar; 8(3): 402-8. PMID: 2155311.

22. Ettinger, D.S., Finkelstein, D.M., Abeloff, M.D., Ruckdeschel, J.C., Aisner, S.C., and Eggleston, J.C.: A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small cell lung cancer. A phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol 1990 Feb; 8(2): 230-40. PMID: 2153765.

23. Resnik CS., Young JWR., Levine AM., Aisner SC.: Osteofibrous dysplasia (ossifying fibroma) of tibia. Skeletal Radiol. 1990; 19 (3): 217-9. PMID: 2333563.

24. Resnik CS., Young JWR., Aisner SC., Levine AM., Dorfman HD.: Metastatic angioblastic meningioma. Skeletal Radiol. 1990; 19 (5): 371-3. PMID: 2377905.

25. Caporaso NE., Tucker MA., Hoover RN., Hayes RB., Pickle LW., Issaq HJ., Muschik G., Green-Gallo L., Buivys D., Aisner SC., Resau J., Trump, BF., Weston A., and Harris C.: Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst. 1990 Aug 1; 82 (15): 1264-72. PMID: 2374176.

26. Young JWR., Aisner SC., Levine AM., Resnik CS., Dorfman HD., Whitley NO.: Computed tomography and magnetic resonance of adamantinoma of long bone. Skeletal Radiol. 1991; 20 (2): 152-6. PMID: 2020866.

27. Resau JH., Albright CD., Cottrell JR., Colombo-Burke KL., Aisner SC., Miura I., Testa, J.R.: Exfoliative cytologic evaluation of primary cultured lung carcinomas. Cytotechnology 1991 Jun; 6 (2): 143-52. PMID: 16724425.

28. Aisner SC., Young JWR., Fine Needle Aspiration Cytology of Osteogenic Sarcoma. Am.Soc.Clin.Path. 1991 (6): C 91-6 (C-216).

29. Aisner SC., Colombo Burke K., Resnik CS. Aspiration cytology of heterotopic ossification. ACTA Cytol. 1992 Mar-Apr; 36(2):159-162. PMID: 1542999.

of 30

30. Shao Z-M., Sheikh MS., Ordonez JV., Feng P., Kute T., Chen, J-C., Aisner, S., Schnaper L., LeRoith, D., Roberts CT., Fontana J.: IGFBP-3 mRNA Expression and estrogen receptor status in human breast carcinoma Cancer Res. 1992 Sep 15:52 (18): 5100-3. PMID: 1381277.

31. Patrone SVM., Resnik CS., Aisner SC., Young JWR.: Acute lymphocytic leukemia presenting as an isolated clavicular lesion. Skeletal Radiol. 1992; 21(8): 546-9. PMID: 1465651.

32. Seidman JD., Oberer S., Bitterman P., Aisner SC.: Pathogenesis of Pseudoxanthomatous Salpingiosis. Modern Pathol. 1993 Jan; 6(1): 53-5. PMID: 8426857.

33. Resnik CS., Aisner SC., Young JWR., Levine AM. Osteosarcoma arising in bone infarction. Skeletal Radiol. 1993l 22 (1): 58-61. PMID: 8430348.

34. Aisner, S.C., Seidman, J.D., Colombo-Burke, K., Young, J.W.R.: Aspiration Cytology of Biphasic and Monophasic Synovial Sarcoma ACTA Cytologica 37:3, 413-417, 1993

35. DeCandido P., Resnik CS., Aisner SC.: Eosinophilic granuloma of bone. Skeletal Radiol. 1993; 22(5): 371-3. PMID; 8372367.

36. Seidman,JD., Borkowski A., Aisner SC., Sun CC.: Rapid Growth of Pseudoangiomatous hyperplasia of Mammary Stroma in Axillary Gynectomastia in an Immunosuppressed Patient. Arch. Path. Lab. Med. 1993 Jul; 117 (7), 736-38. PMID: 8323441.

37. Dundore PA., Aisner, SC., Templeton, PA., Krasna MJ., White CS., Seidman JD.: Nodular Pulmonary Amyloidosis: Diagnosis by Fine Needle Aspiration Cytology. Diagnostic Cytopathology. 1993 Oct; 9(5): 562-4. PMID: 8287768.

38. Bonomi PD., Finkelstein D., Aisner SC., Ettinger D.: EST 2582 Phase II Trial of Cisplatin in Metastatic or Recurrent Thymoma Am. J. Clin Oncol. 1993 Aug; 16(4):342-345. PMID: 8328413.

39. Shao ZM., Sheikh S., Chen J., Kute TE., Aisner SC., Schnaper L., Fontana JF.: Expression of the Retinoic Acid Nuclear Receptors (Rars) and Retinoid x- Receptor (RXR) Genes in Estrogen Receptor Positive and Negative Breast Cancer. Int. J. of Oncology 1994 Apr; 4 (4): 859-63.PMID: 21566993.

40. Linnoila RI., Aisner SC.: The Pathology and Terminology of Lung Cancer, In : Current Concepts in Lung Cancer, (Johnson, D., Johnson, B., ed.) Wiley-Liss, New York, Chapter 4, 55-73, 1995

41. Seidman JD., Schnaper LA., Aisner SC.: Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer. 1995 Jan 1; 75(1) 65-71. PMID 7804979.

42. Hanes DS., Kaufman L., Aisner SC..: Schistosoma haematobium infection of the ectocervix and endocervix associated with cutaneous granuloma. Cl. Infect. Dis. 1994.19: 865 (937).

43. Loehrer PJ., Kim,K., Aisner SC., Livingston R., Einhorn LH., Johnson DH, ,Blum R..: Cisplatin plus -Doxirubrucin plus Cyclophosphamide in Metastatic or recurrent Thymoma:. Final Results of an Intergroup Trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group and Southeastern Cancer Study Group. J. Clin. Oncology 1994 Jun; 12(6): 1164-68. PMID: 8201378.

of 30

44. Aisner SC., Albin RJ., Templeton PJ., Krasna MJ.: Endobronchial Fibrous Histiocytoma Ann. Thorac Surg. 1995 Sep; 60(3): 710-12. PMID: 7677514.

45. Yang HK., Linnoila I., Conrad NK., Krasna MJ., Aisner SC., Johnson BE., Kelley M J.: p53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract. Int J. Cancer. 1995 Aug 22;64 (4): 229-33. PMID: 7657384.

46. Lewis DR., Resnik CS., Aisner SC., Levine AM.,: Chondrosarcoma of the Spinous Process. Skeletal Radiol. 1994 Nov; 23(8): 677-79. PMID: 7886483

47. Dransfeld JW., Resnik CS., Aisner SC., Levine AM.: Osteoblastoma of the fibula. Skeletal Radiol. 1995 Jan; 24(1): 74-5. PMID: 7709263.

48. Li XS., Shao, ZM, Sheikh MS., Eiseman JL., Sentz, D., Jetten AM., Chen JC, Dawson MI., Aisner, S., Rishi AK., Gutierrez P., Schnaper L., Fontana JA.: Retinoic Acid Nuclear Receptor Beta Inhibits Breast Carcinoma Anchorage Independent Growth. J. Cellular Physiol. 1995 Dec; 165(3):449-58. PMID: 7593223.

49. Krasna MJ., White CS., Aisner SC., Templeton MD., McLaughlin JS.: The Role of Thoracoscopy in the Diagnosis of Interstitial Lung Disease. Ann. Thorac. Surg. 1995 Feb; 59 (2): 348-51. PMID: 7847948.

50. Mason, A.C., Aisner, S.C., Templeton, P.A.: Immediate Cytological evaluation in CT-guided Biopsy (letter). Clinical Radiol Feb; 51(2): 151-152. 1995

51. Abdulrahman, R.E., White, C.S., Templeton, P.A., Romney, B., Moore, E.H., Aisner, S.C.: Primary Osteosarcoma of the ribs: CT findings. Skeletal Radiology Feb; 24(2): 127-129, 1995

52. Ord, R.A., Aisner, S.C.: Accuracy of Frozen Sections in Assessing Margins in Oral Cancer Resection. J. Oral and Maxillofacial Surgery 55(7) pp. 663-668, 1997.

53. Han, Q.X., Allegretto, E.A., Shao, Z.M., Kute, T.E., Ordonez, J.V., Aisner, S.C., Rishi, A.K., Fontana, J.A.: Elevated expression of retinoic acid receptor-a (RARa) in estrogen receptor positive carcinomas by immunohistochemistry. Diagnostic Molecular Pathology, Feb; 6(1): 42-8, 1997.

54. de la Roza, G., Burke, K.C., Dumler, J.S., Aisner, S.C.: Aspiration Cytology of Radioiodine-Induced Thyroiditis: Report of a Case and Review of the Literature. Acta Cytologica Vol 41 (4) pp.1369-1372, 1997.

55. Loehrer, P.J., Chen, M., Kim, K., Aisner, S.C., Einhorn, L. H., Livingston, R., Johnson, D.: Cisplatin, Doxorubicin, and Cyclophosphamide Plus Thoracic Radiation Therapy for Limited Stage Unresectable Thymoma: An Intergroup Study. J. Clinical Oncology Vol 15 (9) pp. 3093-3099, 1997.

56. Blacksin, M.F., Siegel, J.R., Benevenia, J. Aisner, S.C.: Synovial Sarcoma: Frequency of Benign MR Imaging Characteristics J.Computerized Assisted Tomography 21 (5): pp 785-789, 1997

57. Hameed, M., Benevenia, J., Blacksin, M., Aisner, S.C.: Nuchal Fibroma of the shoulder involving skeletal muscle. J. Bone & Joint Surgery Vol 80, no 11, 1998

58. Turrisi, A.T., Kyungmann, K., Blum, R., Sause, W.T., Livingston, R.B., Komaki, R., Wagner, H., Aisner, S.C., Johnson, D.T.: Twice Daily Thoracic Radiotherapy versus Once-daily Thoracic

of 30

Radiotherapy in Limited Small Cell Lung Cancer Treated Concurrently with Cisplatin-Etoposide Chemotherapy: A Randomized Intergroup Study of ECOG, SWOG and RTOG. N. Eng. J. Med. Vol 340. no. 4, pp 265-271, 1999.

59. Yuen, A. Zou, G., Turrisi, A., Sause, W., Komaki, R., Wagner, H., Aisner, S.C, Livingston, R., Blum, R., Johnson, D.: Similar Outcome of Elderly Patients in Intergroup Trial 0096: Cisplatin, Etoposide, and Thoracic Radiotherapy Administered Once or Twice Daily in Limited Stage Small Cell Lung Cancer. Cancer Vol. 89 no.9, pp. 1953-1960, 2000.

60. Loehrer, P. J., Jiroutek, M., Aisner, S.C., Aisner, J., Greene, M.R., Thomas, C.R., Livingston, R. B., Johnson, D. H.: Etoposide plus Ifosfomide plus Cisplatin (VIP) in Advanced Thymoma and Thymic Carcinoma: An Intergroup Trial. Cancer June 1:91 (11) 2010-15. 2001.

62. Barbashina, V., Karabakhtsian, R., Aisner, S.C., Bolanowski, P., Patterson, F., Hameed, M.: Desmoplastic Fibroma of the Rib, Arch Pathol Lab Med Vol 126, pp 721-722, 2002.

63. Barbashina, V., Benevenia, J., Aviv, H., Tsai, J., Patterson, F., Aisner, S.C., Cohen, S., Fernandes, H., Skurnick, J., Hameed, M.: Oncoproteins and Proliferation Markers in Synovial Sarcomas: A Clinicopathologic Study of 19 Cases. J. Can Res and Clin Oncol, no. 128: pp 610-616, 2002.

65. Heller, D.S., Hameed, M., Aisner, S.C., Cracchiolo, B., Skurnick, J., Scott, D., Settembre, D.: Demonstration of Her-2 Protein in Cervical Carcinomas. J. Lower Gen. Tract Dis. Vol 7, no.1, pp 7-15, 2003.

66. Das, K., Hameed, M., Heller, D., Mirani, N., Doty, N., Benevenia, J., Patterson, F., Aisner, S.C.: ThinPrep® v. Conventional Smears of Fine Needle Aspirates of Bone and Soft Tissue Tumors, Acta Cytologica, Vol. 47, no 2, pp 197-201, April 2003.

67. Uppal, S., Aviv, H., Patterson, F., Cohen, S., Benevenia, J., Aisner, S.C., Hameed, M.: Alveolar Soft Part Sarcoma: Reciprocal translocation between chromosome 17q25 and Xp11. Report of a case with metastases at presentation and a review of the literature. Acta Orthopedica Belgica. Vol. 69, no. 2, pp. 184-187, 2003.

68. Loehrer, P.J., Wang, W., Johnson, D.H., Aisner, S.C., Ettinger, D.S: Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. Erratum in J. Clin. Oncol. Vol. 22, no. 11, page 2261, 2004 and J. Clin Oncol. Vol. 22, No. 2, 293-9, 2004.

69. Tsai, J.Y., Aviv., H., Benevenia, J., Chang, V.T., Patterson, F., Aisner, S.C., Hameed, M.: HER-2/neu and p53 in Osteosarcoma: An Immunohistochemical and Fluorescence In Situ Hybidization Analysis. Cancer Investigation Vol. 22, No. 1 pp 16-24, 2004.

70. Belani, C.P., Adak, S., Aisner, S.C., Stella, P.J., Levitan, N., Johnson, D.H.: Docetaxel for Malignant Mesothelioma: Phase II Study of The Eastern Cooperative Oncology Group. Cl. Lung Cancer Jul: 6 (1) 43-7, 2004.

71. de la Roza, G., Baredes, S., Aisner, S.C.: Dedifferentiated Liposarcoma of the Cheek, Annals of Diagnostic Pathology Dec;8 (6). 6, pp. 352-7, 2004

of 30

72. Baisre, A., Aisner, S.C., Blacksin, M., Benevenia, J, Hameed, M: Pathologic quiz case: An eighteen year old male with pain and swelling of the left hand. Chondroblastoma Arch. Pathol. Lab. Med. Sep; 128 (9): e 120-121, 2004

73. Tajick, A.G., Ellner, J., Aisner, S.C., Benevenia, J., Blacksin, M., Collins, B.A.: A Twenty eight year old female with right shoulder pain. N J Med. Dec; 101 (12):31-6. 2004

74. Hammar SP, Brambilla C, Pugatch B, Geisinger K, Fernandez EA, Vogt P, Petrovitchev N, Matsuno Y, Aisner S, Rami- Porta R, Capelozzi VL, Schmidt, Carvalho L, Peterson I, Gazdar A, Myerson M, Hanash SM, Jens J, Harris CC. 2004, Squamous cell carcinoma In: Pathology & Genetics: Tumors of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumours, 3rd. Ed. Eds: Travis WD, Brambilla E, Muller-Hermelink and Harris CC, IARC Press. Lyon, France,

75. Hameed, M.R., Lin, T.Z., Coffman, F., Cohen, M., Fernandes, H., Aviv, H., Benevenia, J., Aisner, S.C., Cohen, S.T.: Gene expression analysis of Dedifferentiated Liposarcoma- Differences between high and low grade areas. Analysis of two case and literature review. J. musculoskeletal res. Vol. 9:no.2, pp 77-84, 2005

76. Hameed, M., Aisner, S.C.: EGFR Testing and Interpretation. Chemotherapy Foundation 2004. Cancer Investigation. Vol 23, 2005

77. Hameed MR., Blacksin M., Patterson F., Benevenia J., Aisner SC.: Cortical Chondroblastoma: Report of a Case and a Literature Review of this lesion in unusual locations. Skelet. Radiol. 2006 May; 35 (5):295-7. PMID: 16501973.

78. Blacksin, M.F., Ha, D-H., Hameed, M.R., Aisner, S.C.: Superficial Soft Tissue Masses of the Extremeties. RadioGraphics, 2006 Sep-Oct; 26(5):1289-304. Review.

79. Das, K., Mirani, N., Hameed, M.R., Pliner, L., Aisner, S.C.: Fine needle Aspiration Cytology of Alveolar Rhabdomyosarcoma utilizing ThinPrep® Liquid Based Technology: A Case confirmed by FKHR Break Apart Rearrangement by FISH probe. Diagnostic Cytopathology , October, Vol 34, Issue 10, pp 704-706, 2006

80. Hameed M., Clarke K., Amer HZ., Mahmet K., Aisner SC.: Cellular angiofibroma is genetically similar to Spindle Cell Lipoma. A Case report. Cancer, Genet Cytogenet. 2007 Sep; 177(2):131-4. PMID: 17854668

81. Goodpaster T., Legesse-Miller A., Hameed MR., Aisner SC., Randolph-Habecker J., Coller HA.: An Immunohistochemical Method for Identifying Fibroblasts in Formalin-fixed, Paraffin-embedded Tissue. J. Histochem Cytochem. 2008 Apr; 56 (4) 347-58. PMID: 18071065.

82. Fitzhugh VA., Mirani N., Aisner S.C., Koneru B., Das K.: Preoperative Fine Needle Aspiration Cytology Diagnosis of Microcystic Adenoma of the Pancreas: Fact or Fiction? Report of Two Cases and Review of the Literature. Acta Cytologica 2008; Mar-Apr;52 (2) 240-6. PMID: 18500004.

83. Aisner, S.C., Blacksin, M., Patterson, F., Hameed, M.: A Painful Tibial Mass in a 37 year old Man. Clin. Orth. Rel. Res 2008 Mar; 466 (3): 756-759. PMID: 18202897.

of 30

84. Aisner SC., Beebe K., Blacksin M., Mirani N., Hameed MR.: Alveolar Soft Part Sarcoma of the Fibula demonstrating ASPL-TFE-3 fusion: A Case report and Review of the Literature. Skelet. Radiol. 2008 Nov; 37 (1)1047-51. PMID: 18594808.

85. He M., Aisner SC., Benevenia J., Patterson F., Aviv H., Hameed M.: p16 Immunohistochemistry as an Alternative Marker to Distinguish Atypical Lipomatous Tumor from Deep-Seated Lipoma. Applied Immunohistochemistry & Molecular Morphology. 2009 Jan;17(1): 51-6. PMID: 18779733

86. He, M., Aisner, S.C., Benevenia, J., Patterson, F., Harrison, L, Lin, T.Z., Hameed, M.: 16INK4a gene in dedifferentiation of Liposarcoma. Appl Immunohistochem Mol Morphol. Jan; 17 (1); 51-6, 2009.

87. He, M., Aisner, S.C., Benevenia J., Patterson, F., Harrison, LE, Hameed, M: Epigenetic alteration of p16NK4a gene in dedifferentiation of liposarcoma. Pathol. Res. Pract. 2009; 205(6): 386-394 (Epub 2009 Jan 30). PMID: 19186005

88. Maghari A., Aisner SC., Benevenia J, Hameed M.: Collagenous Fibroma (Desmoplastic fibroblastoma) with a new translocation involving 11q12- A case report. J. Cancer Genetics and Cytogenetics.2009 Jul 15; 192(2): 73-75. PMID: 19596257

89. Aisner S.C., Dahlberg, S., Hameed, M.R., Ettinger, D.S., Schiller, J.H., Johnson,D.H.,

Aisner, J., Loehrer, P. EGFR, c-Kit and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 WHO in patients treated with octreotide and prednisone: An Eastern Cooperative Oncology Group Study. J. Thoracic Oncol. 2010, Jun; 5(6):885-92. PMID: 20421818

90. Zhong M., De Angelo, P., Osborne, L., Keane-Tarchichi, M., Edelman, L., Linehan, W.M., Yang, Y., Marino, M., Aisner, S.C., Hameed, M.: Dual-color, break apart FISH assay

on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell Carcinoma and Alevolar Soft Part Sarcoma. Am. J. Surg Pathol. 2010 Jun; 34(6): 757-66. PMID: 20421778

88. Hong, C., Xu, D.Z., Lu, Q., Cheng, Y., Pisarenko, Y., Doucet, D., Brown, M., Aisner, S.C., Deitch, E., Delphin, E.: Low Tidal Volume and High Positive end-expiratory pressure Mechanical ventilation results in increased inflammation and ventilator-associated lung Injury in normal lungs. Anesth. Analg. 2010 Jun 1; 110(6): 1652-60. Epub 2010 Jan 26. PMID: 20103541

89. Ramalingam, S., Lee, J.W., Belani, C., Aisner, S.C., Kolesar, J., Howe, C., Velasco, M., Schiller, J.: Cetuximab for the treatment for advanced bronchioloalveolar carcinoma

(BAC): An Eastern Cooperative Oncology Group phase II study (ECOG 1504). J. Clin. Oncol. 2011 May, 20 (13): pp 1709-1714. PMID: 21422434

90. Lemma G.L., Lee, J.W., Aisner, S.C., Langer, C.J., Terster, W.C., Johnson, D.H., Loehrer, P.J.: Phase II Study of Carboplatin and Paclitaxel in Advance Thymoma and Thymic Carcinoma. J. Clin. Oncol. 2011 May Vol. 29 (15), pp. 2060-2065. PMID: 21502559

91. Xie, W., Aisner, S.C., Chen, W., Foran, D., Baredes, S., Sreepada, G., Shah, R., Reiss, M.:

Alterations of SMAD expression and activation define two subtypes of human head and neck squamous cell carcinomas. Head and Neck. 2013 Jan; 35(1): 76-85. PMID 22275186

of 30

92. Huang, HF, Shu, P., Murphy TF, Aisner, S, Fitzhugh VA, Jordan, ML: Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer. Mol Cancer Res, 2013 April 11 (4) pp. 427-39. PMID: 23364535

93. Xie, W., Aisner, S., Baredes, S. Sreepada, G., Shah, R., Reiss M: Alerations of Smad

Expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma. Head and Neck, 2013 Jan 35 (1) pp. 76-85. PMID: 22275186

94. Mehta MS., Dolfi, SC., Bronfenbrener R, Bilal E., Chen C., Moore D, Lin Y, Rahim H, Aisner S., Kersellius RD, Teh J. Chen S. Toppmeyer DL, Medina, DJ. Ganesan S. Vazquez A., Hirshfield KM.: Metabotropic glutamate receptor-1 expression and its polymorphic variants associate with breast cancer phenotypes. PloS One 2013 July 26; 8(7) e69851. PMID: 23922822

95. Guo JY., Karsli-Uzunbas G., Mathew R., Aisner SC., Kamphorst JJ., Strohecker AM., Chen G., Price S., Lu W., Teng X., Snyder E., Santanam U., DiPaola RS., Jacks T., Rabinowitz JD., White E. Autophagy Suppresses Progression of K-ras-induced Lung Tumors to Oncocytomas and Maintains Lipid Homeostasis. Genes & Dev. 2013 Jul 1;27 (13): 1447-61. PMID: 23824538

96. Huang, H.F., Shu, P., Murphy, T.F., Aisner, S., Fitzhugh, V.A., Jordan, M.L.: Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer. Mol. Cancer Res. 2013 April 11 (4) pp. 427-439. PMID: 23364535

97. Madhura, S., Mehta, S., Dolfi, C., Bronfenbrener, R., Bilal, E., Chen, C., Moore, D., Lin, Rahim, H., Aisner, S., Romona, D., Kersellius, M., The, J., Chen, S., Toppmeyer, D., Medina, D., Ganesan, S., Vazquez, A., Hirshfield, K.: Metabolic glutamate receptor- 1 expression and its polymorphic variants associate with breast cancer phenotype. PloS One. 2013 July 26; 8(7) e69851. PMID: 23922822

98. Guo, J.Y., Karsli-Uzunbas, G., Mathew, R., Aisner S., Kamphorst, J.J., Strohecker, A. M., Chen, G., Price, S., Lu, W., Teng, X., Snyder, E., Santanam, U., DiPaola, R.S., Jacks, T., Rabinowitz, J.D., White, E.: Autophagy suppresses progression of K-ras- Induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 2013, July 1; 27 (13): 1447-1461. PMID: 23824538

99. Heller DS, Aisner SC, Fitzhugh VA, Katava G, Barrett T.: Pseudoangiomatous Stromal hyperplasia of the vulva presenting as a polypoid vulvar lesion: a

lesion associated with anogenital mammary-like tissue: Report of a case ahd review of the literature. 2013 J. Low Genit Tract Dis. Oct; 17(4): e5-7. PMID 23609586

100. Karp DD, Lee SJ, Shaw GW, Aisner S, Johnson DH, Johnston MR, Goodman G, Okawara G, Marks RS, Frechette E, McCaskill-Stevens W, Ruckdeschel J, Khuri F.: A Randomized, Double Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non-Small Cell Lung Cancer (ECOG 5597). J. Clin Oncol. 2013 Nov 20;31(33) 4179-4187. PMID: 24002495

101. Pillai, RN., Aisner J, Dahlberg S, Rogers JS, Aisner S, Schiller J.:.:Interferon Alpha

(NSC#377523- ECOG 6501) Plus 13-Cis-Retinoic Acid Modulation of BCL-2 Plus Paclitaxel for Recurrent Small Cell Lung Cancer (SCLC). Cancer Chemother Pharmacol, 2014 Vol 74, no. 1. PMID: 24858462

of 30

102. Thunnissen E, Noguchi M, Aisner S, Beasley MB, Brambilla E, Chirieac L, Chung JH, Dacic S, Geisinger K, Hirsch F, Ishikawa Y, Kerr K, Matsuno Y, Minami Y, Moreira A,

Pelosi G, Petersen I, Roggli V, Travis WD, Wistuba I, Yatabe, Y, Witte B, Tsao MS, Nicholson A.: Reproducibility of Histopathological diagnosis in poorly differentiated NSCLC: An International Multi-Observer Study. J Thorac Oncol. 2014 Sep; 9(9): 1354-62. PMID: 25122431

103. Chen W, He M, Benevenia J, Patterson F, Hameed M, Aisner S: Expression of Cell Adhesion, Angiogenesis and Cell Cycle Associated Factors in Osteosarcoma- A Tissue Microarray Study. Applied Immunohistochemistry and Molecular Morphology. (submitted).

104. Porter, D, Serna-Tamayo, C. Zaleski, T., Maghari, A., Zain, H., Patterson, F., Lambert, C. Aisner, S.: High Grade Malignant Fibrous Histiocytoma of the dermis with features of giant cell fibroblastoma arising from an atypical fibrous histiocytoma: case report. Am. J. Dermatol (In Press).

105. Hu S, Lubitz, Aisner S.: Cinacalcet for Management of Tertiary Hyperparathyroidism Associsted with Chronic Treatment of Hypophostphatemia in an Adult with Tumor-Induced Osteomalacia. Am. Assoc of Clinical Endocrinologists EP 14366 (in press).

106. Travis WD, Noguchi M, Yatabe Y, Brambilla E, Nicholson AG, Aisner SC, Austin JHM, Devesea SS, Hirsch F, Ladanyi M, Meyerson M, Mino-Kenudson M, Powell CA, Rami-Porta R, Rekhtman N, Riely G, Russell P, Samet J, Scagliotti G, Thunnissen, To K-F, Tsuta K, van Schil P, Warth A, Wistuba II, Yankelevitz D. : Adenocarcinoma. In; Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015 pp 26-37. Lyon France.

107. Travis WD, Noguchi M, Yatabe Y, Brambilla E, Nicholson AG, Aisner SC, Austin JHM, Ladanyi M, Meyerson M, Mino-Kenudson M, Powell CA, Rami-Porta R, Rekhtman N, Riely G, Russell P, Samet J, Scagliotti G, Thunnissen, To K-F, Tsuta K, van Schil P, Warth A, Wistuba II, Yankelevitz D. : Minimally Invasive Adenocarcinoma. In; Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015, pp 44-46. Lyon France

108. Travis WD, Noguchi M, Yatabe Y, Brambilla E, Nicholson AG, Aisner SC, Austin JHM, Ladanyi M, Meyerson M, Mino-Kenudson M, Powell CA, Rami-Porta R, Rekhtman N, Riely G, Russell P, Samet J, Scagliotti G, Thunnissen, To K-F, Tsuta K, van Schil P, Warth A, Wistuba II, Yankelevitz D. : Atypical adenomatous hyperplasia-Adenocarcinoma in situ. In; Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015, pp 46-50. Lyon, France.

109. Yatabe Y, Brambilla E, Rekhtman N, Aisner SC, Caporaso NE, Gonzalez S, Nicholson AG, Powell Ca, Riley G, Seiworth S, Travis W, van Schil P.: Adenosquamous Carcinoma. In; Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015, pp 86-87, Lyon France.

of 30

110. Travis WD, Yatabe Y, Brambilla E, Ishikawa Y, Nicholson AG, Aisner SC, Austin JHM, Meyerson M, Nakatani Y, Powell CA, Rami-Porta R, Rekhtman N, Reily G, Rossi G, Russell P, Samet J, Scagliotti G, Thunnissen E, Tsuta, K, van Schil P, Warth A, Wistuba II, Yankelevitz D.:Variants of Adenocarcinoma. In; Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015, pp 38-43, Lyon France.

111. Nicholson AG, Geisinger K, Aisner SC, Al-Dayel F, Bubendorf L, Chung J-H, Kerr KM, Meyerson M, Noguchi M, Olszewski W, Rekhtman N, Riely G, Scagliotti G, Travis WD. :Terminology and Criteria in non-resection specimens. In; Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumorous 4th ed. Eds. TravisWD, Brambilla, IARC Press 2015, pp 16-21, Lyon France.

112. Neal JW, Dahlberg SE, Wakelee HA, Aisner SC, Bowden M, Huang Y, Carbone DP, Gerstner GJ, Lerner RE, Rubin JL, Owonikoko TK, Stella PJ, Steen PD, Khalid AA, Ramalingam SS.: Erolotinib, cabozatinib, or erlotinib plus cabozantinib as a second or third line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a phase 2 randomised control trial. Lancet Oncology 2016 Dec; 17 (12): 1661-1671. PMID: 27825638

113. Fitzhugh VA, Wenokor C, Beebe KS, Aisner SC.: Leiomyoma of deep soft tissue mimicking calcific myonecrosis. Radiology Case Reports. 2016:17; 11 (4): 430-433. PMID: 27920874

114. Thunnissen E, Borczuk AC, Flieder DB, Witte B, Beasley MB, Chung JH, Dacic S, Lantuejoul S, Russell PA, den Bakker M, Botling J, Brambilla E, de Cuba E, Geisinger KR, Hiroshima K, Marchevsky AM, Minami Y, Moreira A, Nicholson AG, Yoshida A, Tsao MS, Warth A, Duhig E, Chen G, M, Matsuno Y, Travis WD, Butnor K, Cooper W, Mino-Kenudson M, Motoi N, Poleri C, Pelosi G, Kerr K, Aisner SC, Ishikawa Y, Buettner RH, Keino N, Yatabe Y, Noguchi M.: The Use of Immunohistochemistry Improved the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding set of Cases. J. Thorac Oncol, Feb. 2017; Vol 12, no 2, pp 334-346. PMID: 27998793

115. Belinsky SA, Leng S, Wu G, Thomas CL, Picchi MA, Lee SJ, Aisner S, Ramalingam S, Khuri FR, Karp DD.: Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence. 2017 Cancer Prev Rev (Phila). Nov; 10(11): 635-640. PMID: 28904059

116. Wakelee HA, Dahlberg SE, Keller SM, Tester WJ, Gandara DR, Graziano SL, Adjei A, Leighl NB, Aisner SC, Rothman, JM, Patel JD, Sborov MD, McDermott SR, Perez-Soler R, Traynor A, Butts C, Evans T, Shafqat A, Chapman AE, Kasbari SS, Horn H, Ramalingam SS, Schiller J.: Randomised phase III trial of adjuvant chemotherapy with or without bevacizumab in resected non-small cell lung cancer (NSCLC): Results of E 1505. Lancet oncology, (in press).

Abstracts

of 30

1. Merimee, T.J., Ostrow, P., Aisner, S.C.: Clinical pathological studies in a growth hormone deficient dwarf. Proc. 63rd Annual Meeting of the American Association of Pathologists and Bacteriologists. San Francisco, March 10, 1974.

2. Aisner, S.C., Gupta, P.K., Frost, J.K.: Sputum cytology in pulmonary sarcoidosis. Abst. 4, Proc. 23rd Annual Scientific Meeting of the American Society of Cytology, San Juan, Puerto Rico, November 7, 1975.

3. Aisner, J., Aisner, S.C., Ostrow, S., Govindan, S., Mummert, K., Wiernik, P.: Meningeal carcinomatosis from small cell carcinoma of lung, consequence of improved survival. Proc. 26th Annual Scientific Meeting of the American Society of Cytology, Miami, Florida, November, 1978.

4. Ettinger, D.S., Mehta, C.R., Abeloff, M.D., Ruckdeschel, J.C., Aisner, S.C.: A randomized comparison of conventional chemotherapy with immediate alternation of non-cross resistant chemotherapy in extensive disease small cell lung cancer. Proc. Am. Soc. Clin. Oncol. 5: 170, 1986.

5. Ettinger, D.S., Mehta, C.R., Abeloff, M.D., Ruckdeschel, J.C., Aisner, S.C.: Maintenance chemotherapy versus no maintenance chemotherapy in complete responders following induction chemotherapy in extensive disease (ED) Small Cell Lung Cancer. For the Eastern Cooperation Group. Proc. Am. Soc. Clin. Oncol. 6:175, 1987.

6. Aisner, S.C., Ettinger, D., Mehta, C., Ruckdeschel, J., Abeloff, M., Eggleston, J.: The clinical significance of variant morphology small cell carcinoma of the lung. For the Eastern Cooperative Group. Le Havre, Proc. IASLC Workshop on Combined Modality Therapy of Lung Cancer, June, 1987.

7. Bonomi, P., Aisner, S.C., Ettinger, D., Finkelstein, D.: Phase II trial of cisplatin in recurrent or metastatic malignant thymoma: An ECOG Trial. Proc. Am. Soc. Clin. Oncol. 7: 221, 1988.

8. Aisner, S.C., Ettinger, D., Finkelstein, D., Ruckdeschel, J.D., Mehta, C., Abeloff, M., Eggleston, J.: The clinical significance of variant morphology (small cell/large cell) small cell carcinoma of the lung (SCCL). Proc. Am. Soc. Clin. Oncol. 7: 195, 1988.

9. Trump, B.F., Smith, M.W., Resau, J.H., Jones, R.T., Aisner, S.C.: Pathobiology of lung neoplasia. The role of markers. Proc. Proc. The first Agrigento International Conference on Imaging and Therapy of Lung Cancer, Agrigento, Italy, May, 1988.

10. Caporaso, N.E., Tucker, M.A., Hayers, R.B., Hoover, R., Aisner, S.C., Resau, J., Trump, B.F., Andrews, A.W., Issaq, H.J., Fox, S.D., Muschik, G.M., Weston, A., and Harris, C.C.: Relationship of lung cancer to the urinary excretion of N-nitrosoacids in a case-control study. Proc Am Assoc for Cancer Res, 1989.

11. Caporaso, N.E., Tucker, M.A., Hayes, R., Hoover, R., Aisner, S.C., Resau, J., Trump, B., Issaq, H.J., Muschik, G.M., Weston, A., and Harris, C.C.: Is the ability to metabolize debrisoquine (D) a lung cancer (CA) susceptibility factor or a tumor marker? Proc. Am Soc Clin Oncol 8: 224, 1989.

12. Aisner, S.C., Colombo, K.L., Resnick, C.S., and Levine, A.M.: Aspiration cytology of heterotopic ossification. Proc Am Soc Cytol, 1990

of 30

13. Aisner, S.C., Morris, L.B., Young, J.W.R., and Levine, A.M.: Aspiration cytology of synovial sarcoma. Proc. Am.Soc. Cytol. page 1990.

14. Ruckdeschel, J.C., Linnoila, R.I., Mulshine, J.L., Kim, K., Aisner, S.C., Gazdar, A.F., Jensen, S.N., Bonomi, P.: The impact of neuroendocrine (NE) and Epithelial(EPI) differentiation on response and survival in lung cancer: The ECOG experience. Proc. Am. Soc. Clin. Oncol. 10: 248, 1991

15. Ruckdeschel, J., Linnoila, R.I., Mulshine, J.L., Kim, K., Piantadosi, S., Aisner, S.C.: The impact of neuroendocrine and epithelial differentiation on recurrence and survival in patients with lung cancer. Proc VIth World Conference on Lung Cancer Lung Cancer, 7 Suppl: 56, 1991.

16. Krasna, M.J., White, C.S., Britt, E.J., Aisner, S.C., Templeton, P., McLauglin, J.S.: The Role of Thoracoscopy in the Diagnosis of Interstitial Lung Disease. Chest, 104, 2(9S), 1993.

17. White, C.S., Aisner, S.C., Templeton, P.A., Krasna, M.J.: The Utility of Preoperative CT of Interstitial Lung Disease to Guide Thoracoscopic biopsy. Rad. Soc North America. November 28-December 3, 1993.

18. McDermott,M.P., White, C.S., Borkowski, P., Hisley, C.K., Aisner, S.C.: RADPATH: Medical Teaching Environment that Uses Diagnostic Images with Pathologic Correlation: Rad Soc North America, Radiology, 189 (P) Supplement page 146, November, 1993.

19. Yang, H.K., Kelley, M.J., Linnoila, R.I., Wagner, R. Krasna, M.J., Aisner, S.C., Johnson,B.E.: p53 mutations in multiple primary upper aerodigestive cancers. Am. Assoc. Can. Res. Abst # 3623. Vol 35, pg 608, March 1994

20. Belani, C.P., White, C.S., Slawson, R., Aisner, S.C., Levine, P.A., Templeton, P.A., Krasna, M.J.: Value of Minimally Invasive Thoracoscopy (TS) versus Non-Invasive Staging (NIS) Techniques in Esophageal Cancer (EC). A Step Towards Development of a New Staging System. Proc. Am. Soc. Cl. Onc., Abstract.# 567, 1994

20. Loehrer, P.J., Kim, K., Chen, M., Einhorn, L.H., Aisner, S.C., Livingston, R., Johnson, D.H.: Phase II Trial of Cisplatin (P), Doxorubicin (A), Cyclophosphamide (C) Plus Radiotherapy in Limited Stage Unresectable Thymoma Proc. Am. Soc. Cl. Onc 14:433 (Abstract # 1375), 1995.

21. Papadimitriou, J.C., Drachenberg, C. B., Borquin, P.M., Fricke, W.B., Aisner, S.C: Diffuse Anaplastic Large Cell ki-1 Lymphoma: Correlation of Cytology, Ultrastructure and Immunocytochemistry. Acta Cytologica (Abstract # 328 Volume 39, no.2, pp 342), 1995.

22. Johnson, D.H., Kim, K., Sause, W., Komaki, R., Wagner, H., Aisner, S.C., Livingston, R., Blum, R., Turrisi, A.T.,: Cisplantin and Etoposide + Thoracic Radiotherapy Administered Once or Twice Daily in Limited Disease Small Cell Lung Cancer: Final Report of Intergroup Trial. Proc. Am. Soc. Cl. Onc. Vol 15. ( Abstract # 1113, p.40), 1996.

23. Ord, R.A., Aisner, S.C.: Accuracy of Frozen Sections in Assessing Margins in Oral Cancer Resections. Proc. 4th Intenational Conference on Head and Neck Cancer. (Abstract# 91, page 81), 1996.

24. Benevenia, J., Aisner, S.C., Goltz, D., Zimmerman, M., Aboulafia,A.:Endoprosthetic Replacement after Radical Scapulectomy for Osteosarcoma., Proceedings of the 2nd Osteosarcoma Research Conference., p. 46, Bologna, Italy, 1996.

of 30

25. Aisner, S.C., Turrisi, A., Kim, K.M., Sause, W.T., Livingston, R.B., Livingston, R.B., Einhorn, L., Wagner, H ., Ettinger, D., Komaki, R., Blum, R., Johnson, D.H.: Incidence and significance of Variant Morphology (small cell/large cell) carcinoma in limited stage small cell lung cancer (SCLC). A prospective analysis of an Intergroup ECOG, RTOG and SWOG study. Proc. Am. Soc. Cl. Oncol. Vol. 17 (Abstract # 1764, page 458a) 1998.

26. Ettinger, D., Komaki, R., Blum, R., Johnson, D.H.: Incidence and clinical significance of Variant Morphology (Small Cell\Large Cell) in limited stage small cell lung cancer (SCLC). A prospective analysis of an intergroup ECOG, RTOG and SWOG study. Proc. Am. Soc. Cl. Onc. Vol 17. (Abstract #1764, page 458a), 1998.

27. Loehrer, P.J., Jiroutek, M.: Aisner, S.C., Aisner, J., Greene, M..R., Thomas, C.R., Livingston, R.B., Johnson, D.H.: Phase II Trial of Etoposide (V) Ifosfamide (I) Plus Cisplatin (P) in Patients with Advanced Thymoma (T) or Thymic Carcinoma (TC): Preliminary results from an ECOG Coordinated Intergroup Trial. Proc. Am. Soc. Cl. Onc. Vol 17. (Abstract #118, page 30a), 1998.

28. Barbarshina, V., Benevenia, J., Aisner, S.C, Cohen, S., Fernandes, H., Hameed, M.: Oncogenes and Proliferation markers in synovial sarcoma. Proc. Am. Assoc. Cancer Res. Vol 41 (Abstract # 2761, page 434), 2000

29. Turrisi, A., Kim, K., Sause, W., Komaki, R., Wagner, H., Aisner, S.C., Livingston, R., Blum, R., Johnson, D.: Observations after 5 years Follow-up of Intergroup Trial 0096: 4 cycles of Cisplatin, Etoposide, and concurrent 45 GY Thoracic Radiotherapy given in daily or twice daily fractions followed by 25 GY PCI. Survival differences and patterns of failure. Proc. Am. Soc. Cl. Onc. Vol 17. (Abstract #1757, page 457a), 1998.

30. Yuen A., Zou, G., Turrisi, A., Sause, W., Komaki, R., Wagner, H., Aisner, S.C., Livingston, R., Blum, R., Johnson, D.: Similar outcomes of Elderly Patients in Intergroup Trial 0096: Cisplatin (P), Etopside (E), and Thoracic Radiotherapy (TRT) Administered once (QD) or Twice Daily (BID) in Limited Stage Small Cell Lung Cancer. Proc. Am. Soc. Cl. Onc. Vol 18. (Abstract #1803, page 467a), 1999.

31. Belani, C.P., Adak, S., Aisner, S.C., Stella, P.J., Levitan, N., Johnson, D.H.: Docetaxel for Malignant Mesotheleioma: Phase II Study of the Easteron Cooperative Oncology Group. Proc. Am. Soc. Cl. Onc. Vol 18. ( Abstract # 1829, Page 474a), 1999.

32. Goodin S., Rafi, M.M., Cohen, S., Otasio, F.M., Aisner, S.C., Aisner, J., DiPaola, R.S.: A Phase II Trial of 13 Cis-retinoic acid, Alpha Interferon and Pacitaxel in Patients with advanced Prostate Cancer. Proc. Am. Soc. Clin. Oncol. Vol 19 (Abstract # 1417, page 359a), 2000.

33. Hameed, M.R., Aisner S.C., Patterson, F., Lal, P., Meradian, A., Benevenia, J.: Molecular Markers as Predictors of Biological Behavior in Giant Cell Tumor of Bone. 23rd Annual meeting of the Musculoskeletal Tumor Society. May 14, 2000, Gainesville, Florida

34. Barbashina, V., Benevenia, J., Makarov, V., Grygotis, A., Aisner, S.C., Cohen, S., Hameed, M.: A web based interactive program for teaching bone tumor pathology, 5 th Annual Conference on Advancing Pathology Informatics Imaging, and the Internet, Pittsburgh, October, 2000.

36. Li, H., Benevenia, J., Aisner, S.C., Patterson, F., Settembre, D., Hameed, M.: Chondrosarcoma- Markers for grading and prognosis. Proc. US Canad Pathol, Vol 14 no 1 pp. 13A ,abstract #55, 2001

of 30

37. Heller, D.S., Hameed, M., Aisner, S.C., Cracchiolo, B., Settembre, D.: Demonstration of Her- 2 Protein in Cervical Caricnomas. Proc. Am. Soc. Clin. Oncol. Vol 20 (Abstract #2481, page 183b) 2001.

38. Tsai, J.Y., Aviv, H., Benevenia, J., Patterson, F., Aisner, S.C., Pliner, L., Hameed, M.: Prognostic factors in Osteosarcoma-role of Her-2/neu and p53: an Immunohistochemical (IHC) and Fluorescence in Situ Hybridization (FISH) Analysis. Proc. Am. Soc. Clin. Oncol. Vol 20 (abstract #2933, page 295b), 2001 .

39. Das, K., Hameed, M., Heller, D., Mirani, N., Doty, N., Benevenia, J., Patterson,F., Aisner, S.C.: ThinPrep v. Conventional Smears of Fine Needle Aspirates of Bone and Soft Tissue Tumors, Acta Cytologica, Vol 45, no 5 (Abstract # 104), P 869, 2001.

40. Das, K. Hameed, M., Heller, D., Mirani, N., Doty, Aisner, S.C.: Conventional Smear v. ThinPrep Cytology of Fine Needle Aspirations of Unusual Epithelial and Mesenchymal Lesions. Acta Cytol Vol 45, no.5 (Abstract # 106) P 870, 2001.

41. Barbashina, V., Benevenia, J., Makarov., V., Grygotis, A., Aisner, S.C., Cohen, S., Hameed, M.: A web based interactive program for teaching Bone Tumor Pathology (Abstract). Arch. Pathol Lab. Med. 125:1016, 2001.

42. Loehrer, P.J., Wang, W., Ettinger, D.S., Aisner, S.C., Johnson, D.H.: Phase II Study of Octreotide Treatment in advanced or recurrent thymic malignancies. Proc. Am. Soc. Clin. Oncol Vol 21 ( Abstract #1178, page 295a), 2002

43. Barbashina, V., Sharaan, M., Benevenia, J., Patterson, F., Aisner, S.C., Hameed, M.: Transforming Growth Factor Beta Expression in Extra-Abdominal Fibromatosis: An Immunohistochemical Analysis of TGF Beta, I, II and III. 25th Annual meeting of the Musculoskeletal Tumor Society , Page 60, 2002.

44. Benevenia, J., Bakhos, N.A., Patterson, F.R., Hameed, M.R., Cathcart, C.S., Aisner, S.C., Blacksin, M.F.: Wide resection with Radiation Therapy of Extra-Abdominal Desmoid Tumors. Abst. # 16, 26 th Annual Meeting of the Musculoskeletal Society , May 2, 2003, Chicago, Illinois.

45. Das, K., Fernandes, H., Aisner, S.C., Hameed, M., Mirani, N., Heller, D.: Value of HPV typing using Digene’s Hybrid Capture® 2 HPV test in ThinPrep® material. Am. Soc. Cytol. 2003 Abst. # 10 page 17, 2003.

46. Yang, X.Y., Aviv, H., Aisner, S.C., Benevenia, J., Patterson, F., Cohen, S., Hameed, M.: Cytogenetic Aberrations in Lipomatous Tumors, Proc Am. Soc. Inv. Pathol. Abstract # 166.3 pp. A 267, 2003.

47. Aisner, S.C., Hameed, M.R., Wang, W., Schiller, J.H., Johnson, D.H., Ettinger, D.S., Loehrer, P.J.: EGFR and C-kit immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the WHO: An Eastern Cooperative Oncology Group Study. Proc. Am. Soc. Clin. Oncol. (abst. # 9637, 2004).

48. Loehrer, P.J., Wang, W., Aisner, S.C., Bonomi, P., Einhorn, L.H., Langer, C.J., Johnson, D.H., Schiller, J.: Long Term Follow-up of Patients with Locally advanced or metastatic Thymic Malignancies: The Eastern Cooperative Oncology Group (ECOG) experience. Proc. Am. Soc. Clin. Oncol. (abst. # 7050, pp. 626, 2004)

of 30

49. Karp, D., Ruckdeschel, J., Lee, S., Shaw, G., Keller,S., Beilnsky, S., Aisner, S.C., Kucuk, O, MacDonald, J., Steele, M.: Interim report: A phase III Randomized double blind Chemoprevention Trial of Selenium Supplementation in Persons with resected Stage I Non-Small Cell Lung Cancer. Proc. Int. Assoc. Study Lung Cancer (submitted).

50. Chen, W., Aisner, S.C., Benevenia, J., Patterson, F., Hameed, M.: Expression of p53, 063 and p73 family of genes in Osteosarcoma. Single institution study of 35 patients using tissue microarray. Proc. Am. Soc. Clin. Oncol, Abstract # 9044, page 827s, 2005.

51. Hameed, M.R., Sharer, L., Cho, E., Aisner, S., Cao, L., Tan, A., Mukherjee, A., Chenna, A. Singh, S., Petropoulos, C.: The ERB family receptor dimerization in Glioblastoma—an e-Tag assay analysis of 23 cases. PASCO, Abstract # 32608, June 2006 .

52. He, M., Aisner, S.C., Benevenia, J., Patterson, F., Aviv, H., Hameed, M.: Atypical lipomatous tumors vs. Lipomas: Role of p16- An immunohistochemical analysis of 51 cases. P USCAP (accepted).

53. Karp, D.D., Ruckdeschel, J., Lee, S., Shaw, G., Keller, S., Belinsky, S., Aisner, S.C., Kucuk, O., MacDonald, J., Steele, M: A Phase III randomized double blind chemoprevention trial of selenium supplementation in persons with resected stage 1 non-small cell lung cancer: A six-year update. Proc. AACR , # B150, November 15, 2006, page59.

54. Xie, W., Aisner, S.C., Baredes, S., Sreepada., G., Shah, R., Reiss, M.: Tissue MicroarrayAnalysis of Human Head and Neck Squamous Cell Carcinomas. The 2006 Annual Retreat on Cancer Research in New Jersey, May 25, 2006. Piscataway, New Jersey

55. He, M., Aisner, S.C., Benevenia, J., Patterson, Lin, T., Hameed, M.: Epigenetic alteration of p16 is involved in dedifferentiation of liposarcoma. Proc. USCAP, San Diego, March 2007.

56. Chen, W., He, M., Aisner, S.C., Malliah, R., Benevenia, J., Patterson, F., Hameed, M:Expression of cell cycle, angiogenesis and metastases associated factors in Osteosarcoma- Immunohistochemical analysis of tissue array in 35 patients. PASCO, Abstract # 10036, June, 2007, Chicago, Illinois.

57. He, M., Aisner, S.C., Benevenia, J., Patterson, Aviv, H., Hameed, M.: p16 as a marker to differentiate atypical lipomatous tumor/well-differentiated liposarcoma from deep seated lipoma: An immunohistochemical analysis of 51 cases. PASCO, Abstract # 10070, June, 2007, Chicago, Illinois.

58. Hameed, M., Blacksin, M., Aisner, S.C., Benevenia, J.: Case Presentation Coccidiomycosis of The Humerus, Budapest, Hungary. October 2007

59. Aisner, J., Dahlberg, S., Rodgers, S., Aisner, S.C., Schiller, J.H.: Interferon alpha (IA) + 13-Cis-Retinoic Acid modulation of BCL-2 + paclitaxel for recurrent SCLC. PASCO, June 2008, abstract # 19048, page 710s.

60. Wang, Q., Aisner, S.C., Benevenia, J., Patterson, F., Beebe, K., Pliner, L., Hameed, M.: Differentiation-Association Antigen Expression Profile of Primary Bone Diffuse Large B Cell Lymphoma (DLBCL) - Analysis of 31 Cases. U.S. College Am. Pathologists (USCAP). March 2006

61. Xie, W., Aisner, S.C., Baredes, S., Sreepada, G., Shah, R., Reiss, M.: High expression of Cyclin E2 is associated with poorly differentiated and advanced stage of human head and neck

of 30

squamous cell carcinoma. Proc. Am. Assoc. Cancer Res., Vol. 48: p1228; April , 2007 Los Angeles, California.

62. Hong, C.M., Xu, D.Z., Lu, Q., Cheng, Y., Pisarenko, V., Doucet, D., Brown, M., Aisner, S.C., Zhang, C., Deitch, E., Delphin, E.: Low Tidal Volume and High Positive-End

Expiratory Pressure Mechanical Ventilation Increase Pulmonary Inflammatory Response and Ventilator-Induced Lung Injury in Normal Lung. Soc.Cardiovac Anesth, June 20, 2008.

63. Hong, C.M., Xu, D.Z., Lu, Q., Cheng, Y., Pisarenko, V., Doucet, D., Brown, M., Aisner, S.C., Zhang, C., Deitch, E., Delphin, E.: The Effects of Different Ventilator Strategies on

Inflammation and Lung Injury in Normal Lungs. Am. Soc. Anesth.,Oct, 2008

64. Hameed, M., Blacksin, M., Aisner, S.C., Benevenia, J.: Case Presentation #5: CompositeHemangioendothelioma of femur. Skeletal Radiology, New Delhi, India, October, 2008

65. Xie, W., Aisner, S.C., Baredes, S., Sreepada, G., Shah, R., Reiss, M.: Alterations of

TGF-B/Smads signaling in human head and neck squamous cell carcinoma. Annual Retreat on Cancer Research in New Jersey, p 99; May 26, 209, Piscataway, New Jersey

66. Zhong, M., De Angelo, P, Osborne, L., Merino, M., Hameed, M., Aisner, S.C..: The Study of Xp11 Translocation Renal Cell Carcinoma (RCC) in Adults with TMA, IHC and FISH.

USCAP, March 2010.

67. Ramalingam, S., Lee, J.W., Belani, C.P., Aisner, S.C., Kolesar, J., Howe, C., Velasco, M.R., Schiller, J.H.: Cetuximabe for the treatment of advanced bronchiol- alveolar carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504) PASCO, # 7522, June 2010

68. Fitzhugh VA, Patterson F, Benevenia J, Aisner SC, Hameed MR.: Prognostic Factors in Synovial Sarcoma. Poster Presentation. United States and Canadian Academy of Pathology, Denver, Colorado. March 4, 2008.

69. Chen W, He M, Benevenia J, Patterson F, Hameed M, Aisner S.: Prognostic Value of B-Catenin and Ezrin in Osteosarcoma; An immunohistochemical Investigation using tissue array.Soc. Ped. Path March 2013.

70. Pillai RN, Lee SJ, Karp DD, Aisner S, Ramalingam SS, Khuri F.: Second Primary Lung Cancer: Analysis of E5597 Selenium Chemoprevention Study. Proc. Am.Soc.Clin.Oncolog, June 2014

71. Neal JW, Dahlberg SE, Wakelee HA, Aisner S, Bowden M, Carbone DP, Ramalingam SS.: Cabozantinib (C) , erlotinib (E) or the combination (E+C) as 2nd or 3rd line therapy in patients with wild type (wt) NSCLC: a randomized phase 2 trial of the ECOG-ACRIN Cancer Research Group (E1512). Proc. Am. Soc. Clin. Oncology, June 2015.

72. Wakelee HA, Dahlberg SE, Keller SM, Tester WJ, Gandara DR, Graziano SL, Adaji A, Leighl N, Aisner SC, Rothman JM, Patel J, Sporov MD, McDermott SR, Perez-Soler R, Traynor AM, Butts C, Evans T, Horn L, Ramalingam SR, Schiller J.: Randomized Phase III Trial of Adjuvant Chemotherapy with and without Bevacizumab in Resected Non-Small Cell Lung Cancer (NSCLC). Results of E1505 Abst # Plen 04.03. Int. Assoc Study Lung Cancer, Denver, CO, Sept 2015.

of 30

73. Neal JW, Dahlberg SE, Wakelee HA, Aisner S, Bowden M, Carbone DP, Ramalingam SS.: A randomized phase II trial of Cabozantinib (C) , erlotinib (E) or the combination (E+C) as 2nd or 3rd

line therapy in patients with wild type (wt) NSCLC: a randomized phase 2 trial of the ECOG-ACRIN Cancer Research Group (E1512). Abst Mini 30.04 . Int. Assoc Study Lung Cancer, Denver, CO, Sept 2015.

74. Wakelee HA, Dahlberg SE, Keller SM, Tester WJ, Gandara DR, Granizano SL, Adjei AA, Leighl N, Butts CA, Aisner S, Rothman JM, Patel JD, Sborov MD, McDermott SR, Perez-Soler R, Traynor AM, Evans TL, Horn L, Ramalingam S, Schiller JH.: E1505 Adjuvant Chemotherapy +/- Bevacizumab for early state NSCLC: Outcomes based on Chemotherapy subsets. Proc. Am. Soc. Clin. Oncology, June 2016

75. Fitzhugh V, Baisre A, Blacksin M, Aisner S: Mycobacterium Avium Intracellulare of the sacral spine in an immunocompromised host with systemic lupus erythematosus and juvenile rheumatoid arthritis. International Skeletal Society, Paris, France, September 2016

76. Hu T, Colangelo NW, Domogauer JD, Schwartzkoph C, Howell RW, de Toledo SM, Aisner S, Azzam, EI: Exposure of mice to space radiation modulates the abundance of haematopoietic cells and inflammatory cytokines. 62nd Annual International Radiation Research Society, Waikoloa, Hawaii, October 16-19, 2016

77. Aisner S, Blacksin M, Curcio C, Nuttall J, Patterson F.: So called benign fibrous histiocytoma of bone (NOF) with necrosis. International Skeletal Society, New York City, New York, Case # 28, August 29, 2017.

78. Aisner S, Blacksin M, Curcio C, Nuttall J, Beebe K.: Granulomatous tuberculosis (TB) osteomyeliltis, septic arthritis and abscess. International Skeletal Society, New York City, New York, Case # E3, August 28, 2017.

Photographic Exhibitions:

1. Aisner, S.C., Todesco, J.: VonRecklinghausen's disease. International Meeting of the Biologic Photographers and Health Science Communicators Association, Toronto, Canada, July, 1981 - Honorable Mention.

2. Aisner, S.C., Todesco, J.: Pigmented basal cell carcinoma. International Meeting of the Biological Photographers and Health Science Communicators Association, San Diego, California, July 1982 - Honorable Mention.

3. Aisner, S.C., Todesco, J.: Benign cementoblastoma. International Meeting of the Biological Photographers and Health Science Communicators Association, San Diego, California, July 1982.

of 30

4. Aisner, S.C., Todesco, J.: Look-a-likes in malignant melanoma. International Meeting of the Biologic Photographers and Health Science Communicators Association, Dallas, Texas, July, 1983. Poster session Exhibition - Chosen as one of ten out of 104 entries as a Valuable Teaching Tool, Medical Educational Resource and a Publishable Work.

Invited Presentations and Participations:

1. Aisner, S.C.: "Laboratory Assisted Diagnosis." The Johns Hopkins School of Medicine and Allied Health Continuing Education Course for Primary Care Practitioners, September 30, 1976.

2. Aisner, S.C.: "Histopathologic Classification of Lung Cancer." Lung Cancer Current Trends and Future Prospects Symposium, Brussels, Belgium, June 15, 1984.

3. Aisner, S.C.: "Review and Current Status of Small Cell Lung Cancer Pathology." Proceedings of the Second IASLC Workshop on Small Cell Lung Cancer. GleneaglesScotland, September 10, 1984.

4. Aisner, S.C.: "Role of the Pathologist in ECOG Protocols." ECOG Data Manager Symposium, Chicago, Illinois, June 18, 1986.

5. Aisner, S.C.: "Pathology of Mesothelioma." Joint Program on the U.S.- Finland Mesothelioma Cooperative Group, May 19, 1988, Bethesda, MD.

6. Aisner, S.C.: "Classification and Biology of Lung Cancer." Current Concepts in Lung Cancer, Hospital La Paz, Madrid, February 24-25, 1989.

7. Aisner, S.C.: "Aspiration Cytology of Bone and Soft Tissue Tumors." Maryland Association of Cytotechnology, Baltimore, Maryland, March 14, 1990.

8. Aisner, S.C.: "The Clinical Utility of Fine Needle Aspiration Cytology of Primary and Metastatic Tumors of Bone and Soft tissue." University of Maryland Cancer Center, Grand Rounds. Baltimore, Maryland, May 31, 1990.

9. Aisner, S.C.: "Take the Pap Smear Challenge." 9th Annual Update in Obstetrics and Gynecology. Annapolis, Maryland, June 28-29, 1990.

10. Aisner, S.C.: "The Clinical Significance of Variant Small Cell Lung Cancer and Neuroendocrine Markers in Lung Cancer" United States - Japan Cooperative Cancer Research Program Symposium on Lung Cancer Research. Okayama, Japan, November 12, 1990.

11. Aisner, S.C.: "The Clinical Significance of Immunohistochemical Analysis of Non-Small Cell and Small Cell Lung Cancer." The Johns Hopkins Oncology Center, The Johns Hopkins Hospital, January 15, 1991.

of 30

12. Aisner, S.C.: "The Pap smear in the 90's" Dean's Conference #5. Health Issues for Men and Women. University of Maryland School of Medicine, Baltimore, Maryland, March 21, 1991.

13. Aisner, S.C.: "Prognosis and Neuroendocrine Markers in Lung Cancer." Lung Cancer: Current Concepts and Therapies. University of Maryland Cancer Center Symposium, Baltimore, Maryland, December 13, 1991.

14. Aisner, S.C.: " Fine needle aspiration cytology of primary neoplasms of bone." Georgetown University Department of Pathology, June 22, 1992.

15. Aisner, S.C.: " Aspiration Cytology of Bone and Soft Tissue Tumors and its Radiologic and Clinical Correlation." National Institutes of Health, November 13, 1992

16. Aisner, S.C.:" Variant morphology small cell lung cancer (SCLC): Laboratory, morphologic or clinical reality?" Fourth International Association for the Study of Lung Cancer Tumor Biology Workshop, Airlie, Virginia April 16, 1993.

17. Aisner, S.C.: "Redefining Neuroendocrine Neoplasms of the Lung." 3rd Central European Lung Cancer Conference, Prague, The Czech Republic, May 30, 1995.

18. Aisner, S.C.: " What can the Pathologist tell the Oncologist apart from giving the diagnosis of Non-small Cell Lung Cancer?" 4th Central European Lung Cancer Conference, Gdansk, Poland, September 27, 1996.

19. Aisner, S.C., Haselton, P.: " The changing classification of Neuroendocrine Carcinomas of the Lung." 8th World Conference on Lung Cancer, Dublin, Ireland, August 14, 1997.

20. Aisner, S.C., Lung Cancer Pathology Review, 9th World Congress on Lung Cancer, Tokyo, Japan, September 12, 2000

21. Aisner, S.C. Fine needle Aspiration Cytology of Bone and Soft Tissue Lesions. Robert Wood Johnson University Hospital, New Brunswick, New Jersey, December 9, 2003

22. Aisner, S.C., Lung Cancer Differentiation. Network for Medical Communication and Research., San Francisco, December 2, 2006.

23. Aisner, S.C., Lung Cancer Differentiation. Network for Medical Communication and Research, Atlanta, May 19, 2007

24. Aisner, S.C., Fine Needle Aspiration Cytology of Bone and Soft tissue lesions., Tata Memorial Hospital, Mumbai, India, October 22, 2008.

25. Fitzhugh VA, Wenokor C, Aisner SC. Chondromyxoid Fibroma. Miscellaneous Bone Tumor Session. International Skeletal Society. Rome, Italy. September 11, 2012

26. Fitzhugh VA, Wenokor C., Aisner SC.: Amyloidoma Mimicking a Fibrohistiocytic Lesion. Miscellaneous Bone Soft Tissue Section. International Skeletal Society. Rome, Italy. September 11, 2102

27. Aisner SC, Fitzhugh VA, Wenokor C, Benevenia.: Primary metaphyseal Chondroblastoma Presenting Radiologically as an Osteoblastoma. International Skeletal Society, PhiladelphiaPennsylvania, September 30, 2013.

of 30

28. Fitzhugh V, Ramirez D, Baisre A, Wenokor C, Aisner SC.: Coccidiodes Osteomyelitis of the Spine as a Sequela of Disseminated Coccidiodes. International Skeletal Society Presentation #1, Edinburgh, Scotland, October 14, 2014.

29. Fitzhugh VA, Ramirez DC, Beebe KS, Wenokor C, Aisner SC.: Kaposi Sarcoma in an HIV Negative Patient with Metastasis to the left fifth Metatarsal. International Skeletal Society Presentation #37, Edinburgh, Scotland, October 15, 2014.

30. Fitzhugh VA, Patterson F, Wenokor C, Aisner SC.: Epithelioid Sarcoma of Bone. Maui, Hawaii, September 28, 2015.

WORKSHOPS

Aisner, S.C., Solomon, D.: Fine Needle Aspiration Cytology of Bone and Soft Tissue Tumors. American Society for Clinical Pathology, Orlando, Florida Presented October, 1993.Presented April, 1995.

24. Books, Monographs and Chapters

1. Trump, B.F., Smith, M.W., Resau, J.H., Jones, R.T., Aisner, S.C.: Pathobiology of lung neoplasia. The role of markers and ion deregulation. In: Lung Cancer. Advanced Concepts and Present Status. Mota G (ed). Grafica LP, Genoa, pp. 39-44, 1989.

2. Aisner, S.C.: Clasificacion histologica e historia natural del cancer de pulmon. In: Gonzalez-Baron, M. (Ed) Avances En Cancer De Pulmon. Coordinacion Editorial: Gallery, S.A. Madrid, Spain 1990, pp 65-82.

3. Aisner, J., Belani, C.P., Aisner, S.C.: Tumors of the Pleura and Mediastinum. In: Clinical Oncology 3rd edition, Abeloff, M.D., Armtiage, J.O., Niederhuber, J.E., Kastan, M.B., McKenna, W.G. (Eds): Elsevier Churchill Livingston, New York, Chapter 76, pgs. 1745-1786., 2004.

4. Sovak, M, Aisner, S.C., Aisner, J: Tumors of the Pleura and Mediastinum. In: Clinical Oncology 4th edition, Abeloff, M.D., Armitage, J.O., Niederhuber, J.E., Kastan, M.D., McKenna, W.G. (Eds): Elsevier Churchill Livingston, New York Chapter 77, pgs. 1367-1398. 2007.

B. Patents HeldNone

C. Other Articles (Reviews, Editorials, etc.) In Journals; Chapters; Books; other Professional Communications

1. Aisner SC: Review: Clinical Cytopathology and Aspiration Biopsy: Fundamental Principles and Practice (Ramzy, I, Ed). Norwalk, CT, Appleton and Lange, 427 p., 1990. N. Engl. J. Med. 323: 139, 1990.

of 30

2. Aisner SC: Review: Biopsy Interpretation of the Lung. Biopsy Interpretations Series. Shimosato, Y., and Miller, R.R., New York, New York. Raven Press, 1994, Lung Cancer 12(1995) 109-110

3. Aisner, SC: Review: The Art and Science of Cytopathology. Richard M. DeMay. Chicago, American Society of Clinical Pathologists, N. Engl. J. Med Vol. 335 # 23, pp. 1774, 1996.

of 30

university curriculum vitae format€¦ · web viewcurriculum vitae date: april 30, 2018 name:...

Documents